Literature DB >> 81287

Antifibrinolytic therapy of subarachnoid hemorrhage by intrathecal administration of p-aminomethylbenzoic acid.

R Heidrich, F Markwardt, S Endler, P Hindersin.   

Abstract

In patients suffering from subarachnoid hemorrhage (SAH), intrathecal administration of p-aminomethylbenzoic acid (PAMBA) was found to produce hemostatically effective concentrations of the antifibrinolytic agent in the cerebrospinal fluid (CSF). The early clinical findings speak in favor of this mode of administration.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 81287     DOI： 10.1007/BF00313371

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


  7 in total

1.  Fibrinolytic activity in the walls of cerebral saccular aneurysms.

Authors:  O Hassler; H Fodstad
Journal:  Acta Neurochir (Wien)       Date:  1977       Impact factor: 2.216

2.  [Hemostatic processes in aneurysmal hemorrhages].

Authors:  P Hindersin; R Heidrich
Journal:  Psychiatr Neurol Med Psychol (Leipz)       Date:  1977-03

3.  Letter: E-aminocaproic acid and subarachnoid haemorrhage.

Authors:  D Uttley; A E Richardson
Journal:  Lancet       Date:  1974-11-02       Impact factor: 79.321

4.  The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage.

Authors:  D Tovi
Journal:  Acta Neurol Scand       Date:  1973       Impact factor: 3.209

5.  Preoperative management of patients with ruptured intracranial aneurysms.

Authors:  J Ransohoff; A Goodgold; M V Benjamin
Journal:  J Neurosurg       Date:  1972-05       Impact factor: 5.115

6.  Antifibrinolytic therapy for intracranial aneurysms.

Authors:  S Mullan; J Dawley
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

7.  Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage.

Authors:  D W Nibbelink; J C Torner; W G Henderson
Journal:  Stroke       Date:  1975 Nov-Dec       Impact factor: 7.914
  7 in total
  2 in total

1.  Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study.

Authors:  S A Tsementzis; E R Hitchcock; C H Meyer
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

2.  Subarachnoid hemorrhage and the distribution of drugs delivered into the cerebrospinal fluid. Laboratory investigation.

Authors:  Ryszard M Pluta; John A Butman; Bawarjan Schatlo; Dennis L Johnson; Edward H Oldfield
Journal:  J Neurosurg       Date:  2009-11       Impact factor: 5.115
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.